Clinical trials: Arteriovenous Fistulae
Arteriovenous Fistula Occlusion
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis
The narrowing of Dialysis Fistulae or Grafts is a near universal problem in patients with end-stage renal disease (ESRD) and requires patients to undergo repeated angioplasty or mechanical opening of the fistula.
- Trial name
- NCT03106948
- Testing
- Ascorbic Acid, Cuprimine Oral Product
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Southeast Renal Research Institute